company-logo

Genomma Lab Internacional, S.A.B. de C.V., together with its subsidiaries, engages in the development, marketing, and sale of over-the-counter pharmaceutical and personal care products in Mexico and internationally. It provides skin care, health and wellness, hair care, pain relief, cough and cold, gastro, sexual health, antiperspirant deodorant, hand sanitizer, isotonic deink, and razor products, as well as analgesics, antifungals, and hemorrhoids. The company offers its products under the Cicatricure, Asepxia, Teatrical, Goicoechea, Sistema GB, Medicasp, Tío Nacho, Vanart, Novamil, Ultra Bengue, X-Ray, Tafirol, Alliviax, Bufferin, Next, XL-3, Genoprazol, QG5, Kaopectate, Proctan, Nikzon, Unesia, Silka Medic, lagicam, Suerox, Groomen, DiabetTX, and other brands. Genomma Lab Internacional, S.A.B. de C.V. was incorporated in 1996 and is based in Mexico City, Mexico.

Genomma Lab Internacional Dividend Announcement

Genomma Lab Internacional announced a quarterly dividend of Mex$0.20 per ordinary share which will be made payable on . Ex dividend date: 2024-09-13
Genomma Lab Internacional annual dividend for 2024 was Mex$0.79
Genomma Lab Internacional annual dividend for 2023 was Mex$0.59
Genomma Lab Internacional's trailing twelve-month (TTM) dividend yield is 4.37%
Genomma Lab Internacional's payout ratio for the trailing twelve months (TTM) is 37.17%

Genomma Lab Internacional Dividend History

Ex-Div dateDividend amountDividend typePay date
2024-09-13Mex$0.20quarterly
2024-06-20Mex$0.20quarterly
2024-03-22Mex$0.20quarterly
2024-03-21Mex$0.20quarterly
2023-12-22Mex$0.20quarterly
2023-09-28Mex$0.20quarterly
2023-06-05Mex$0.20quarterly
2022-11-09Mex$0.38quarterly
2022-06-06Mex$0.38quarterly
2021-12-08Mex$0.38quarterly
2021-12-01Mex$0.76quarterly

Genomma Lab Internacional Dividend per year

Genomma Lab Internacional Dividend growth

Genomma Lab Internacional Dividend Yield

Genomma Lab Internacional current trailing twelve-month (TTM) dividend yield is 4.37%. Interested in purchasing Genomma Lab Internacional stock? Use our calculator to estimate your expected dividend yield:

Genomma Lab Internacional Financial Ratios

P/E ratio16.96
PEG ratio0.81
P/B ratio2.44
ROE15.66%
Payout ratio37.17%
Current ratio1.81
Quick ratio1.48
Cash Ratio0.27

Genomma Lab Internacional Dividend FAQ

Does Genomma Lab Internacional stock pay dividends?
Genomma Lab Internacional does not currently pay dividends to its shareholders.
Has Genomma Lab Internacional ever paid a dividend?
No, Genomma Lab Internacional has no a history of paying dividends to its shareholders. Genomma Lab Internacional is not known for its dividend payments.
Why doesn't Genomma Lab Internacional pay dividends?
There are several potential reasons why Genomma Lab Internacional would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Genomma Lab Internacional ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Genomma Lab Internacional has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Genomma Lab Internacional a dividend aristocrat?
Genomma Lab Internacional is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Genomma Lab Internacional a dividend king?
Genomma Lab Internacional is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Genomma Lab Internacional a dividend stock?
No, Genomma Lab Internacional is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Genomma Lab Internacional stocks?
To buy Genomma Lab Internacional you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Genomma Lab Internacional stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.